Tianyu Pharmaceutical

Zhejiang Tianyu Pharmaceutical is a leading global manufacturer of active pharmaceutical ingredients (APIs) and intermediates, specializing in small molecule chemistry. The company is particularly renowned for its large-scale production of sartan family antihypertensive drugs, such as valsartan and losartan, holding a significant share of the global market. Beyond cardiovascular health, Tianyu provides comprehensive CDMO services and produces APIs for anti-diabetic, anti-viral, and anti-coagulant therapies. Headquartered in Taizhou, China, the company operates multiple GMP-compliant manufacturing facilities and maintains a strong presence in regulated markets including the US, EU, and Japan. Tianyu is listed on the Shenzhen Stock Exchange and continues to invest in R&D to expand its portfolio of complex generic APIs.